Today, our screeners were at work and below is a list of 3 HealthTech Stocks up over 66% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
Summary: Entera Bio Ltd. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of orally delivered molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone for hypoparathyroidism and osteoporosis. Entera Bio Ltd. is based in Jerusalem, Israel.
Recent ENTX Stock Price (approx 10:00am EST.): $1.15
Previous Close for ENTX Stock: $1.02
Percentage Price Change Past 10 Days for ENTX stock: +82%
What is the forecast for ENTX stock? Here are 3rd party ratings for ENTX stock:
|
What’s the sentiment on the street for ENTX stock? Current ratings compiled by TipRanks.com)
|
Click for the ENTX stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: 9 Meters Biopharma, Inc. is a rare, orphan and unmet needs focused GI company. It's advancing NM-002, a proprietary long-acting GLP-1 agonist into Phase 2 trial for Short Bowel Syndrome, a rare, orphan disease, as well as larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom. 9 Meters Biopharma Inc., formerly known as Innovate Bioph, is based in Raleigh, United States.
Recent NMTR Stock Price (approx 10:00am EST.): $2.21
Previous Close for NMTR Stock: $1.45
Percentage Price Change Past 10 Days for NMTR stock: +81%
What is the forecast for NMTR stock? Here are 3rd party ratings for NMTR stock:
|
What’s the sentiment on the street for NMTR stock? Current ratings compiled by TipRanks.com)
|
Click for the NMTR stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Jounce Therapeutics Inc., JNCE
Summary: Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates.
Recent JNCE Stock Price (approx 10:00am EST.): $1.29
Previous Close for JNCE Stock: $1.09
Percentage Price Change Past 10 Days for JNCE stock: +66%
What is the forecast for JNCE stock? Here are 3rd party ratings for JNCE stock:
|
What’s the sentiment on the street for JNCE stock? Current ratings compiled by TipRanks.com)
|
Click for the JNCE stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.